- Home
- BZUN vs SCPH Comparison
BZUN vs SCPH Comparison
Compare BZUN & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- SCPH
- Stock Information
- Founded
- BZUN 2007
- SCPH 2013
- Country
- BZUN China
- SCPH United States
- Employees
- BZUN N/A
- SCPH N/A
- Industry
- BZUN Catalog/Specialty Distribution
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- BZUN Consumer Discretionary
- SCPH Health Care
- Exchange
- BZUN Nasdaq
- SCPH Nasdaq
- Market Cap
- BZUN 275.9M
- SCPH 299.0M
- IPO Year
- BZUN N/A
- SCPH 2017
- Fundamental
- Price
- BZUN $4.41
- SCPH $5.62
- Analyst Decision
- BZUN Strong Buy
- SCPH Buy
- Analyst Count
- BZUN 1
- SCPH 3
- Target Price
- BZUN $4.20
- SCPH $12.00
- AVG Volume (30 Days)
- BZUN 735.7K
- SCPH 2.4M
- Earning Date
- BZUN 08-28-2025
- SCPH 11-12-2025
- Dividend Yield
- BZUN N/A
- SCPH N/A
- EPS Growth
- BZUN N/A
- SCPH N/A
- EPS
- BZUN N/A
- SCPH N/A
- Revenue
- BZUN $1,349,630,922.00
- SCPH $49,969,000.00
- Revenue This Year
- BZUN $5.27
- SCPH $104.30
- Revenue Next Year
- BZUN $3.46
- SCPH $76.06
- P/E Ratio
- BZUN N/A
- SCPH N/A
- Revenue Growth
- BZUN 7.73
- SCPH 107.79
- 52 Week Low
- BZUN $2.12
- SCPH $1.94
- 52 Week High
- BZUN $4.88
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- BZUN 65.67
- SCPH 63.32
- Support Level
- BZUN $4.32
- SCPH $4.33
- Resistance Level
- BZUN $4.67
- SCPH $5.62
- Average True Range (ATR)
- BZUN 0.34
- SCPH 0.04
- MACD
- BZUN 0.06
- SCPH -0.01
- Stochastic Oscillator
- BZUN 73.74
- SCPH 80.00
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.